The Reimbursement Code Your Medtech Startup Is Counting On Doesn't Exist Yet
Most medtech founders assume a CPT or ICD code will be waiting when they're ready to sell. Here's why that assumption will wreck your commercial timeline.
W. Osei Topic
deep tech
20 posts tagged deep tech from Lab to Launch.
W. Osei More on deep tech
The Reference Customer You're About to Name in Your Pitch Deck Is Going to Call You a Liar
Before you put a customer logo in your pitch deck, understand exactly what that relationship actually means and what they'll say when investors call.
W. OseiThe Conflict of Interest Your Scientific Advisor Never Disclosed Will Torpedo Your Deal
Your scientific advisor's undisclosed competing interests can blow up a funding round or partnership deal. Here's what to find before it's too late.
W. OseiThe Investor Update Email You've Been Sending Is Actively Hurting Your Fundraise
Your monthly investor update feels like good practice, but the way most founders write it quietly closes doors before the next round even opens.
W. OseiThe Cap Table Your Seed Investor Just Signed Will Haunt Every Future Round
The cap table mistakes deep tech founders make at seed stage don't show up until Series A, when they're nearly impossible to fix.
W. OseiThe Data Package Your Potential Acquirer Requested Is a Fishing Expedition
When a big company asks for your technical data package, they're not always serious buyers. Here's how to tell the difference and protect yourself.
W. OseiThe License Agreement Your University Wants You to Sign Will Strangle Your Startup
Before you sign that exclusive license from your university tech transfer office, understand exactly which clauses will make you unfundable and unsellable.
W. OseiThe Strategic Partnership MOU Your Fortune 500 Contact Sent You Is a Stall Tactic
That MOU from a big corporate partner feels like validation, but it's often a delay mechanism. Here's how to tell the difference and what to do about it.
W. OseiThe Non-Disclosure Agreement Your Potential Partner Sent You Is a Trap
That NDA from your potential industry partner looks standard. It probably isn't. Here's what deep tech founders miss before they sign.
W. OseiThe Clinical Advisor You Just Recruited Has No Idea How to Get You Paid
Your clinical advisor is brilliant and respected. But if they can't talk reimbursement codes, they may be the most expensive hire you never paid for.
W. OseiThe Prototype You Built in the Lab Is Not a Product and Never Will Be
Your lab prototype proves the science works. It proves almost nothing about whether you can build a real product. Here's what changes between bench and shelf.
W. OseiThe Due Diligence Data Room You Built Will Actually Kill Your Deal
Most deep tech founders build their investor data room to impress, not to close. Here's why that instinct backfires and what to do instead.
W. OseiThe Pilot Agreement That Will Trap You Inside a Single Customer Forever
That pilot deal with your first big customer feels like validation. It might actually be the contract that kills your startup's growth before it starts.
W. OseiThe Accelerator Program That Will Waste Six Months of Your Runway
Not every accelerator is built for deep tech founders. Here's how to tell which ones will drain your runway instead of building your company.
W. OseiWhy Your First Licensing Deal Will Cost You More Than You Made
Licensing your deep tech looks like free money, until the audits, sublicensing traps, and milestone clawbacks hit. Here's what to watch.
W. OseiThe IP Assignment Agreement You Didn't Read Will End Your Startup
Before you raise a dollar or sign a co-founder, understand who actually owns your invention, because your university might.
W. OseiWhy Your Grant-Funded Proof of Concept Is Lying to You
Grant funding lets you control every variable. That's exactly why your proof-of-concept data may be telling you a story that doesn't survive first contact with a real market.
W. OseiHow to Pitch Deep Tech to Non-Technical Investors Without Losing Your Soul
Technical founders often tank investor pitches by over-explaining the science. Here's how to translate your research into language that closes rounds.
W. OseiWhy Your First FDA Meeting Will Feel Like Academic Hazing
What biotech founders really face in their first FDA pre-submission meeting and how to survive the regulatory reality check.
W. OseiYour Lab Equipment Budget vs. Real-World Manufacturing Costs: A Reality Check
Why that $500K mass spectrometer in your lab doesn't translate to viable manufacturing economics for your startup.
W. Osei Browse more topics